Adial Pharmaceuticals- Warrants (31/07/2023) Accounts Payable

The latest accounts payable for ADILW is $2.6M as of June 2026. That compares with $670K in the prior-year period — up 291.0% year over year. Investors often review this figure alongside Adial Pharmaceuticals- Warrants (31/07/2023)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ADILW's accounts payable moved from $670K to $2.6M — a 291.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Adial Pharmaceuticals- Warrants (31/07/2023)'s operating scale or balance-sheet position.

A accounts payable figure of $2.6M for ADILW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ADILW's accounts payable ($2.6M), review year-over-year change from $670K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Adial Pharmaceuticals- Warrants (31/07/2023)'s accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.